Buscar resultados de ensayos clínicos

Patrocinado por

Gastro-enteropancreatic Neuroendocrine Tumor - 18 Studies Found

Estado Estudiar
Active, not recruiting Nombre del estudio: Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
Condición: Gastroenteropancreatic Neuroendocrine Tumors
Fecha: 2014-09-02
Intervenciones:
  • Drug: Lanreotide Autogel 120 mg

Completed Nombre del estudio: 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
Condición: Gastroenteropancreatic Neuroendocrine Tumors
Fecha: 2014-06-03
Intervenciones: Drug: 68Ga-OPS202
Completed Nombre del estudio: 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
Condición: Gastroenteropancreatic Neuroendocrine Tumors
Fecha: 2013-04-25
Intervenciones: Drug: Intravenous injection of 177Lu-octreotate Treatment will consist of 177Lu-octreotate injections in
Completed Nombre del estudio: Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
Condición: Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
Fecha: 2010-12-16
Intervenciones:
  • Drug: Pasireotide LAR followed by Pasireotide LAR + Everolimus
Not yet recruiting Nombre del estudio: TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
Condición:
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Temozolomid
    Fecha: 2017-03-09
    Intervenciones: Drug: TEMCAP Oral capecitabine 750 mg/m2 twice a day, Day 1 to 14 and oral temozolomide 200 mg/m2 once a
Completed Nombre del estudio: Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
Condición:
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Lung Neuroendocrine
    Fecha: 2016-10-27
    Intervenciones: Procedure: NETest 5 mL of blood will be drawn from participants for testing.
Active, not recruiting Nombre del estudio: The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Condición:
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • Secondary Malignan
    Fecha: 2011-08-24
    Intervenciones: Other: magnetic resonance imaging (MRI) Each patient will
COMPLETED Nombre del estudio: A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly
Condición: Gastro-enteropancreatic Neuroendocrine Tumor
Fecha: 2025-11-04
<<< Previous